Jazz Pharmaceuticals (JAZZ) Inventory Average (2011 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Inventory Average of $427.2 million for Q1 2026, down 12.2% year-over-year from $486.6 million in Q1 2025, and down 5.07% quarter-over-quarter from $450.1 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Inventory Average (2011 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Inventory Average history runs 16 years deep, the most recent figure standing at $427.2 million for Q1 2026.
- In Q1 2026, Inventory Average fell 12.2% year-over-year to $427.2 million; the TTM figure through Mar 2026 stood at $427.2 million (down 12.2% YoY), while the FY2025 annual figure was $448.7 million, down 16.71% from the prior year.
- Inventory Average for Q1 2026 stood at $427.2 million, down from $450.1 million in the prior quarter.
- The five-year high for Inventory Average was $1.0 billion in Q1 2022, with the low at $427.2 million in Q1 2026.
- The 5-year median for Inventory Average is $587.2 million (2024), against an average of $624.9 million.
- Peak annual rise in Inventory Average reached 876.04% in 2022, while the deepest fall reached 34.76% in 2022.
- Jazz Pharmaceuticals' Inventory Average stood at $721.1 million in 2022, then decreased by 16.18% to $604.4 million in 2023, then decreased by 15.64% to $509.9 million in 2024, then retreated by 11.73% to $450.1 million in 2025, then slipped by 5.07% to $427.2 million in 2026.
- Business Quant data shows JAZZ's Inventory Average at $427.2 million in Q1 2026, $450.1 million in Q4 2025, and $494.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 440.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 440.25 Mn |
| Mar 31, 2026 | 427.25 Mn |
| Dec 31, 2025 | 450.06 Mn |
| Sep 30, 2025 | 494.05 Mn |
| Jun 30, 2025 | 498.88 Mn |
| Mar 31, 2025 | 486.61 Mn |
| Dec 31, 2024 | 509.87 Mn |
| Sep 30, 2024 | 540.93 Mn |
| Jun 30, 2024 | 559.94 Mn |
| Mar 31, 2024 | 587.18 Mn |
| Dec 31, 2023 | 604.43 Mn |
| Sep 30, 2023 | 634.52 Mn |
| Jun 30, 2023 | 666.00 Mn |
| Mar 31, 2023 | 694.42 Mn |
| Dec 31, 2022 | 721.07 Mn |
| Sep 30, 2022 | 794.89 Mn |
| Jun 30, 2022 | 923.58 Mn |
| Mar 31, 2022 | 1.03 Bn |
| Dec 31, 2021 | 1.11 Bn |
| Sep 30, 2021 | 1.19 Bn |